[PDF][PDF] Reflections on the complex history of the concept of clozapine-induced inflammation during titration

J de Leon - Psychiatria Danubina, 2022 - hrcak.srce.hr
REFLECTIONS ON THE COMPLEX HISTORY OF THE CONCEPT OF CLOZAPINE-INDUCED
INFLAMMATION DURING TITRATION Page 1 411 Psychiatria Danubina, 2022; Vol. 34, No. 3 …

A systematic review of clozapine‐associated inflammation and related monitoring

JG Leung, L Zhang, M Markota… - … : The Journal of …, 2023 - Wiley Online Library
Clozapine is an effective antipsychotic medication used for treatment‐resistant
schizophrenia. However, it is underutilized due to rigorous hematologic monitoring …

[HTML][HTML] Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK

C De las Cuevas, EJ Sanz, JA Gross, CU Correll… - Schizophrenia …, 2024 - Elsevier
Background Pharmacovigilance studies indicate clozapine history is marked by adverse
drug reactions (ADRs). Objective In a 2021 article, the United Kingdom (UK) had> 90% of …

[HTML][HTML] Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the …

R de Filippis, C De las Cuevas, EJ Sanz… - Schizophrenia …, 2024 - Elsevier
Background The literature has paid very little attention to pericarditis, pericardial effusion
and pancreatitis during clozapine treatment in children and adolescents. Methods Cases of …

Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases

R de Filippis, JM Kane, N Kuzo, E Spina… - European …, 2022 - Elsevier
Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS)
syndrome is a rare adverse reaction. We aimed to screen a large pharmacovigilance …

[PDF][PDF] Clozapine in treatment-resistant schizophrenia: Reflections from the Hallmark US clinical trial and beyond

JM Kane, G Schoretsanitis, JM Rubio… - Schizophrenia …, 2024 - zora.uzh.ch
We read with interest Gilbert Honigfeld's article entitled “Clozapine in treatment-resistant
schizophrenia: Who designed that famous US clinical trial?”(Honigfeld, 2023) published in …

Rethinking clozapine: lights and shadows of a revolutionary drug

L Dell'Osso, C Bonelli, B Nardi, F Giovannoni… - Brain Sciences, 2024 - mdpi.com
The current literature globally highlights the efficacy of Clozapine in several psychiatric
disorders all over the world, with an FDA indication for reducing the risk of repeated suicidal …

Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia

M Qubad, RA Bittner - Therapeutic Advances in …, 2023 - journals.sagepub.com
Despite its enduring relevance as the single most effective and important evidence-based
treatment for schizophrenia, underutilization of clozapine remains considerable. To a …

Pharmacovigilance approaches to study rare and very rare side-effects: the example of clozapine-related DiHS/DRESS syndrome

R de Filippis, P De Fazio, JM Kane… - Expert Opinion on …, 2022 - Taylor & Francis
Adverse drug reactions (ADRs) are considered rare or very rare events when they occur,
respectively, between≥ 1/10,000 and< 1/1,000, or< 1/10,000 drug expositions [1]. The …

New approaches to antipsychotic medication adherence–safety, tolerability and acceptability

S Taub, A Krivoy, E Whiskey… - Expert Opinion on Drug …, 2022 - Taylor & Francis
Introduction Antipsychotic pharmacotherapy is considered a first-line treatment in
schizophrenia-related disorders and is associated with favorable prognosis and lower …